Professor John E Brazier
BA (Exeter), MSc (York), PhD (91Ö±²¥)
Population Health, School of Medicine and Population Health
Emeritus Professor
Full contact details
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
91Ö±²¥
S1 4DA
- Profile
-
I am Emeritus Professor in the School of Health and Related Research (ScHARR) at the University of 91Ö±²¥. I have been a health economist for 40 years. My special interest is in the measurement and valuation of health for economic evaluation where I have published widely.
I am perhaps best known for my work in developing a preference-based measure of health for the SF-36 (SF-6D), but with colleagues have further developed and extended these methods to a number of specific conditions including measures in asthma, cancer, overactive bladder, diabetes, mental health, dementia and epilepsy. Most recently with colleagues across six countries developed a new generic measure of health and wellbeing called the EQ-HWB for health and social care users and their informal carers.
My methods research has also examined issues around reviewing utility measures, mapping between measures, valuation methods (including the use of DCE), using utilities in cost effectiveness models and developing ways to incorporate equity concerns such as burden of disease into the weights applied to QALYs and the role of well-being in economic evaluation. I have been a member of the National Institute for Clinical Excellence (NICE) Technology Appraisal Committee and has been an adviser on various aspects benefit measurement to NICE.
- Publications
-
Show: Featured publications All publications
Featured publications
Books
Journal articles
- . Value in Health, 22(1), 62-68.
- . Medical Decision Making, 38(6), 699-707.
- . The British journal of psychiatry : the journal of mental science, 212(1), 42-49.
- . Value in Health.
- . European Journal of Health Economics.
- . Medical Decision Making, 36(2), 210-222.
- . Applied Health Economics and Health Policy, 13(6), 557-565.
- . Social Science & Medicine, 120, 12-20.
- . Br J Psychiatry, 202(3), 220-227.
- . Med Care, 42(9), 851-859.
- . J Health Econ, 21(2), 271-292.
- Decision analytic modelling in the economics evaluation of health care technologies: a consensus statement. PharmacoEconomics(4), 161-163.
- Decision Analytic modelling in the Economic Evaluation of Health Technologies: A consensus statement. PharmacoEconomics, 5(17), 443-444.
All publications
Books
- Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press.
- Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press.
- Methods in Health Technology Assessment. London: Sage Books.
- Methods for Health Services Research: a state of the art guide.. London: BMJ Books.
Journal articles
- Development of the CFQ-R-8D: estimating utilities from the cystic fibrosis questionnaire-revised. Value in Health.
- . Quality of Life Research.
- . Value in Health.
- . Journal of Patient-Reported Outcomes, 6(1).
- . Value in Health.
- . Value in Health.
- . Wellcome Open Research, 7.
- . Value in Health.
- . Value in Health.
- . PharmacoEconomics, 39(10), 1151-1162.
- . The European Journal of Health Economics.
- . Value in Health, 24, S193-S193.
- . PharmacoEconomics.
- . Value in Health.
- . PharmacoEconomics.
- . Eur J Health Econ.
- . BMC Medical Research Methodology, 21.
- . PharmacoEconomics.
- . Value in Health, 24(2), 281-290.
- . Medical Decision Making, 41(1), 89-99.
- . Value in Health, 23, S715-S715.
- . Value in Health, 23, S430-S430.
- . PharmacoEconomics.
- . Value in Health, 23(10), 1391-1399.
- . Trials, 21(1).
- . Journal of Attention Disorders.
- . Value in Health.
- . Medical Care, 58(6), 557-565.
- . Medical Care.
- . Value in Health, 23(3), 397-405.
- . Quality of Life Research.
- . International Journal of Environmental Research and Public Health, 17(3).
- . Quality of Life Research.
- . Health Economics, 28(12), 1385-1401.
- . Wellcome Open Research, 4.
- . Value in Health.
- . Value in Health, 22(7), 837-842.
- . Journal of Medical Economics.
- . Applied Health Economics and Health Policy, 17(3), 295-313.
- . Value in Health, 22, S327-S328.
- . Value in Health, 22, S326-S327.
- . Health and Quality of Life Outcomes, 17.
- . BMJ Open, 9.
- . Value in Health, 22(3), 267-275.
- . The Patient - Patient-Centered Outcomes Research, 1-13.
- . PharmacoEconomics, 37(3), 293-299.
- . Economies, 7(1).
- . Der Ophthalmologe, 116(12), 1186-1193.
- . Value in Health, 22(1), 62-68.
- . Ophthalmologica, 241(2), 61-72.
- . Quality of Life Research.
- . Health and Quality of Life Outcomes, 16.
- . Clinical Therapeutics, 40(11), 1878-1893.e1.
- . Eye (Basingstoke).
- . Value in Health, 21, S469-S470.
- . Journal of Patient-Reported Outcomes.
- . Value in Health.
- . Health and Quality of Life Outcomes, 16.
- . Medical Decision Making, 38(6), 699-707.
- . International Journal of Environmental Research and Public Health, 15(7), 1342-1342.
- . PharmacoEconomics, 36, 637-640.
- . PharmacoEconomics, 36(6), 729-729.
- . The British journal of psychiatry : the journal of mental science, 212(1), 42-49.
- . Health Economics, 27(1), 4-6.
- . Value in Health, 21(1), 69-77.
- . Phamacoeconomics.
- . PharmacoEconomics.
- . PharmacoEconomics, 35(Suppl 1), 7-9.
- . PharmacoEconomics.
- . PharmacoEconomics, 35(Suppl 1), 77-88.
- . PharmacoEconomics, 35(Suppl 1), 43-55.
- . PharmacoEconomics, 35(Suppl 1), 21-31.
- . PharmacoEconomics, 35(Suppl 1), 33-41.
- . International Journal of Geriatric Psychiatry, 32(12), 1392-1400.
- . The European Journal of Health Economics.
- . Investigative Ophthalmology and Visual Science, 58(11), 4818-4825.
- . Diabetic Medicine, 34(9), 1264-1275.
- . Health and Quality of Life Outcomes, 15.
- . Value in Health.
- . European Journal of Health Economics.
- . European Journal of Health Economics, 19(4), 557-570.
- . Health and Quality of Life Outcomes, 15.
- . Value in Health, 20(4), 687-693.
- . Trials, 18(1), 93-93.
- . Quality of Life Research, 26(3), 749-759.
- . BMC Health Services Research, 17(1), 78-78.
- . PharmacoEconomics, 35(4), 439-451.
- . Social Science & Medicine, 172, 80-88.
- . Qual Life Res.
- . European Child & Adolescent Psychiatry, 25(11), 1217-1231.
- . Acta Crystallographica Section A Foundations and Advances, 72(a1), s49-s50.
- . Social Science & Medicine, 157, 48-59.
- . BMJ Open Diabetes Research and Care, 4(1).
- . ChemPhysChem, 17(9), 1388-1388.
- . Quality of Life Research, 25(3), 625-636.
- . PharmacoEconomics, 34(7), 645-649.
- . ChemPhysChem, 17(9), 1281-1287.
- . Medical Decision Making, 36(2), 210-222.
- . Applied Health Economics and Health Policy, 14(1), 89-104.
- Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference 91Ö±²¥ 2016: advances in patient reported outcomes research : 91Ö±²¥, UK. 9th June 2016. Health and quality of life outcomes, 14(Suppl 1).
- . Quality of Life Research, 25(3), 637-649.
- . The European Journal of Health Economics, 17(7), 801-809.
- . Health Economics (United Kingdom), 25(4), 486-496.
- A Portuguese Value Set for the SF-6D (vol 13, pg 624, 2010). VALUE IN HEALTH, 18(8), 1162-1162.
- Exploring the Consistency of the SF-6D (vol 16, pg 1023, 2013). VALUE IN HEALTH, 18(8), 1162-1162.
- . The European Journal of Health Economics, 16(9), 927-939.
- . Health and Quality of Life Outcomes, 13(1).
- . Value in Health, 18(7), A469-A469.
- . PharmacoEconomics, 33(11), 1101-1105.
- . Nature Chemistry, 7(12), 961-967.
- Valuing the SF-6D Version 2 in Canada. QUALITY OF LIFE RESEARCH, 24, 180-181.
- . Medical Decision Making, 35(7), 912-926.
- . Applied Health Economics and Health Policy, 13(6), 557-565.
- . Value in Health, 18(6), 846-855.
- . Acta Crystallographica Section A Foundations and Advances, 71(a1), s492-s493.
- . Bioorg Med Chem Lett, 25(16), 3307-3310.
- . Applied Health Economics and Health Policy, 13(5), 485-492.
- . Value in Health, 18(3), A27-A27.
- . Medical Decision Making, 35(3), 328-340.
- . Health and Quality of Life Outcomes, 13(1), 24-24.
- . Quality of Life Research, 24(2), 305-314.
- . Value in Health, 18(4), 432-438.
- . Value in Health, 18(1), 52-60.
- . Medical Decision Making, 35(1), 68-80.
- . European Journal of Health Economics, 16(2), 141-151.
- . Journal of the American Chemical Society, 136(50), 17505-17512.
- . Value in Health, 17(7), A570-A570.
- . Value in Health, 17(7), A517-A517.
- . Value in Health, 17(7), A493-A493.
- . Social Science & Medicine, 120, 12-20.
- The development of cancer-specific multi-attribute utility instruments from the EORTC QLQ-C30 and FACT-G. QUALITY OF LIFE RESEARCH, 23, 28-29.
- . Br J Psychiatry, 205(3), 236-243.
- . Med Decis Making, 34(6), 773-786.
- . BMC Research Notes, 7(1).
- . Value Health, 17(4), 406-415.
- . Epilepsy Behav, 36, 12-17.
- . Health Technology Assessment, 18(34).
- . Health and Quality of Life Outcomes, 12(1).
- . JAMA Ophthalmol, 132(3), 310-318.
- . Value in Health.
- . Value in Health.
- . Medical Decision Making, 34(1), 42-53.
- . European Journal of Health Economics, 15(1), 7-18.
- . Health Technol Assess, 18(9), 1-224.
- . Health Technol Assess, 18(12), vii-191.
- . BMC Ophthalmol, 13, 74.
- . Quality of Life Research, 1-16.
- . Trials, 14, 302.
- . Value Health, 16(6), 1023-1031.
- . Value in Health, 16(6), 1032-1045.
- . Quality of Life Research, 22(7), 1831-1840.
- . Medical Decision Making, 33(6), 793-803.
- . Value in Health, 16(4), 686-695.
- . Med Decis Making, 33(6), 839-852.
- . Journal of Health Economics, 32(2), 486-486.
- . J Pers Disord, 27(3), 383-401.
- . Health Technol Assess, 17(5), v-140.
- . Br J Psychiatry, 202(3), 220-227.
- . Health and Quality of Life Outcomes, 11(1), 210-210.
- . Quality of Life Research, 1-10.
- . Health Economics (United Kingdom).
- . Value in Health, 16(1), 177-184.
- . Value Health, 16(1), 104-113.
- . Med Decis Making, 33(3), 381-395.
- . Value Health, 15(8), 1059-1068.
- . Health Qual Life Outcomes, 10, 138.
- . Chemical Communications, 48(87), 10739-10739.
- Revaluing the SF-6D using ordinal methods for eliciting preferences. QUALITY OF LIFE RESEARCH, 21, 6-6.
- Are generic preference-based measures valid in mental health? A mixed methods enquiry. QUALITY OF LIFE RESEARCH, 21, 1-1.
- Monitoring outcomes for the Medicare Advantage program: methods and application of the VR-12 for evaluation of plans.. The Journal of ambulatory care management, 35(4), 263-276.
- . Eye (Basingstoke), 26(10), 1295-1301.
- . J Ambul Care Manage, 35(4), 263-276.
- . Value Health, 15(5), 787-788.
- . Health Technol Assess, 16(32), 1-114.
- . Anaerobe, 18(2), 197-199.
- . HEALTH TECHNOLOGY ASSESSMENT, 16(16), 1-+.
- . HEALTH AND QUALITY OF LIFE OUTCOMES, 10.
- . PLOS ONE, 7(2).
- . Social Science and Medicine.
- . Value in Health, 15(5), 730-736.
- . Value in Health, 15(2), 323-333.
- . Value in Health, 15(2), 346-356.
- . PharmacoEconomics, 30(8), 713-727.
- . Health Outcomes Research in Medicine, 3(3).
- . Epilepsy and Behavior, 24(1), 36-43.
- . Value Health, 15(1), 118-127.
- . J Health Econ, 31(1), 306-318.
- . Pharmacoeconomics, 30(1), 47-61.
- . Med Care, 50(5), 452-459.
- . Qual Life Res, 21(3), 465-473.
- . Med Decis Making, 32(1), 31-40.
- . Health Economics, 21(6), 715-729.
- . Qual Life Res, 21(10), 1731-1743.
- . Eur J Health Econ, 13(5), 575-587.
- . PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 4(4), 247-257.
- . Heart Surg Forum, 14(6), E330-E334.
- . QUAL LIFE RES, 20(9), 1477-1486.
- . QUAL LIFE RES, 20(8), 1337-1347.
- . Value Health, 14(6), 907-920.
- . Value Health, 14(5), 721-731.
- . Value Health, 14(5), 740-745.
- . Value Health, 14(4), 539-545.
- Health state utilities for skeletal-related events associated with bone metastases.. J Clin Oncol, 29(15_suppl), e16620.
- . JOURNAL OF CLINICAL ONCOLOGY, 29(15).
- . SOC SCI MED, 72(10), 1717-1727.
- . Soc Sci Med, 72(11), 1904-1912.
- . Med Decis Making, 31(2), 281-291.
- Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(6 SUPPL 6), 17-21.
- . VALUE IN HEALTH, 14(1), 24-33.
- An assessment of the construct validity of the CHU9D in the Australian adolescent general population. Quality of Life Research, 1-9.
- Using mixed methods research to explore the effect of an adaptation exercise on general population valuations of health states. Quality of Life Research, 1-9.
- . Value in Health, 14(5 SUPPL.).
- Rasch analysis in the development of a simplified version of the national eye institute visual-function questionnaire-25 for utility estimation. Quality of Life Research, 1-12.
- . Soc Sci Med, 73(2), 245-253.
- . Quality of Life Research, 20(3), 321-333.
- . Med Decis Making, 31(1), 195-210.
- . Applied Health Economics and Health Policy, 9(1), 15-27.
- . Qual Life Res, 20(4), 609-619.
- . Health Qual Life Outcomes, 8, 141.
- . Value in Health, 13(7), A380-A381.
- . Value in Health, 13(7), a472.
- Developing preference-based measures from existing quality of life measures: why, how and should we?. QUALITY OF LIFE RESEARCH, 19, 2-2.
- Development and Comparisons of Alternative Preference-Based Measures of Health. QUALITY OF LIFE RESEARCH, 19, 2-2.
- . Expert Rev Pharmacoecon Outcomes Res, 10(5), 553-566.
- . J Clin Nurs, 19(19-20), 2673-2703.
- . CURR MED RES OPIN, 26(8), 1893-1903.
- . QUAL LIFE RES, 19(6), 853-864.
- . STAT MED, 29(15), 1622-1634.
- . VALUE HEALTH, 13(5), 624-630.
- . Value Health, 13(6), 787-795.
- . Focus on Alternative and Complementary Therapies, 7(1), 113-113.
- . Focus on Alternative and Complementary Therapies, 6(1), 93-94.
- . Qual Life Res, 19(6), 907-917.
- . Eur J Health Econ, 11(2), 215-225.
- . Value Health, 13(5), 509-518.
- . J CLIN NURS, 19(5-6), 892-897.
- . HEALTH ECON, 19(2), 125-129.
- . BMC Public Health, 10, 3.
- . Value Health, 13(2), 298-305.
- . J Clin Epidemiol, 62(12), 1323-1331.
- . HEALTH ECON, 18(11), 1261-1276.
- . HEALTH SERV RES, 44(4), 1406-1423.
- . Osteoporos Int, 20(6), 853-868.
- . QUAL LIFE RES, 18(4), 509-518.
- . Value Health, 12(5), 793-799.
- . Health Econ, 18(3), 363-372.
- . Qual Life Res, 18(2), 253-265.
- . Health Qual Life Outcomes, 7, 27.
- . Pharmacoeconomics, 27(9), 705-712.
- . Value in Health, 2(12), 346-353.
- . Value Health, 11(7), 1131-1143.
- . J Health Serv Res Policy, 13 Suppl 3, 70-75.
- . HEALTH QUAL LIFE OUT, 6.
- . ARTHRIT RHEUM-ARTHR, 59(7), 1018-1026.
- . Financial Accountability and Management, 1(2), 173-189.
- . Nucleosides Nucleotides & Nucleic Acids, 27(4), 431-431.
- . QUAL LIFE RES, 17(3), 453-462.
- . VALUE HEALTH, 11(2), 295-303.
- . Journal of Medical Economics, 11(2), 215-233.
- . Pharmacoeconomics, 26(9), 769-779.
- . Med Decis Making, 28(1), 113-126.
- A review and critique of modelling in prioritising and designing screening programmes.. Health technology assessment (Winchester, England), 11(52).
- A review and critique of modelling in prioritising and designing screening programmes. HEALTH TECHNOL ASSES, 11(52), 1-+.
- . J Psychosom Res, 63(6), 625-632.
- . Eye (Lond), 21(12), 1455-1463.
- . J Health Econ, 26(5), 992-1002.
- . ARTHRIT RHEUM-ARTHR, 57(6), 963-971.
- The Role of Condition Specific Measures in Economic Evaluation: It's a Trade-Off.
- . J Adv Nurs, 58(5), 458-467.
- . J HEALTH ECON, 26(3), 597-612.
- . Health Econ, 16(4), 395-405.
- . Qual Life Res, 16(3), 533-543.
- . SOC SCI MED, 64(6), 1242-1252.
- Response to Shmueli. Health Economics, 16(7), 759-761.
- . Nursing Standard, 21(45), 57-69.
- . J Health Serv Res Policy, 12(1), 56-58.
- A review and critique of modelling in prioritising and designing screening programmes.. Health technology assessment (Winchester, England), 11(52).
- . Pharmacoeconomics, 25(8), 685-693.
- . J Bone Miner Res, 22(1), 135-141.
- . Journal of Health Services Research and Policy, 12(3), 190-191.
- . HEALTH QUAL LIFE OUT, 4.
- . BMJ, 333(7569), 626.
- . BMJ, 333(7569), 623.
- . Health Technol Assess, 10(33), iii-168.
- . Health Technol Assess, 10(35), iii-117.
- . Health Economics, 15(7), 761-761.
- . Health Econ, 15(6), 543-551.
- . J Health Econ, 25(3), 418-431.
- Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). HEALTH TECHNOL ASSES, 10(13), III-+.
- . HEALTH QUAL LIFE OUT, 4.
- . J Health Econ, 25(2), 334-346.
- . Br J Surg, 93(2), 182-186.
- . Br J Surg, 93(2), 175-181.
- . Health Econ, 15(1), 1-4.
- . Invest Ophthalmol Vis Sci, 46(11), 4016-4023.
- . J Mol Biol, 353(3), 692-703.
- Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.. Health technology assessment (Winchester, England), 9(32).
- . Health Technol Assess, 9(32), iii-109.
- . Qual Life Res, 14(6), 1523-1532.
- . Br J Dermatol, 153(2), 372-377.
- . Expert Rev Pharmacoecon Outcomes Res, 5(3), 245-254.
- . QUAL LIFE RES, 14(5), 1333-1344.
- . Med Care, 43(6), 627-635.
- Estimating utilities from individual health preference data: a nonparametric Bayesian method. J ROY STAT SOC C-APP, 54, 879-895.
- . HEALTH ECON, 14(4), 339-347.
- . SOC SCI MED, 60(7), 1571-1582.
- . Health Econ, 14(3), 231-244.
- Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women. J OPER RES SOC, 56(2), 214-221.
- . Applied Health Economics and Health Policy, 4(4), 219-228.
- A cost survey of 70 adult critical care units - Results from a volunteer sample in England, Scotland and Northern Ireland in 2003. Care of the Critically Ill, 21(1), 8-17.
- Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.. Health technology assessment (Winchester, England), 9(32).
- . Appl Health Econ Health Policy, 4(4), 201-208.
- . Health Qual Life Outcomes, 3, 13.
- . J Epidemiol Community Health, 58(12), 1004-1010.
- . BMJ, 329(7465), 571.1-571.1.
- Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. VALUE HEALTH, 7(5), 602-609.
- . Health Econ, 13(9), 873-884.
- . Med Care, 42(9), 851-859.
- . Value Health, 7(4), 490-498.
- NICE clinical guidelines [2] (multiple letters). British Medical Journal, 329(7465), 571-572.
- . British Medical Journal, 328(7439), 536-537.
- . DIGESTION, 69(4), 254-261.
- . Medical Decision Making, 23(6), 542-543.
- . HEALTH ECON, 12(11), 975-981.
- . Expert Rev Pharmacoecon Outcomes Res, 3(3), 293-302.
- . COMPLEMENT THER MED, 11(2), 78-84.
- . Health Services and Outcomes Research Methodology, 4(1), 35-47.
- . Health Qual Life Outcomes, 1, 4.
- . Osteoporos Int, 13(10), 768-776.
- . Acupuncture in Medicine, 20(2-3), 121-137.
- Patient-determined quality of life measure in critical limb ischaemia. BRIT J SURG, 89(4), 526-526.
- . J Health Econ, 21(2), 271-292.
- Treatment of established osteoporosis: a systematic review and cost-utility analysis.. Health technology assessment (Winchester, England), 6(29), 1-146.
- Treatment of established osteoporosis: A systematic review and cost-utility analysis. Health Technology Assessment, 6(29).
- Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. MED DECIS MAKING, 22(1), 27-38.
- . Health Econ, 11(1), 17-19.
- . Health Technol Assess, 6(29), 1-146.
- . Pharmacoeconomics, 20(7), 455-462.
- . Value in Health, 4(2), 130-130.
- . Value in Health, 4(2), 71-71.
- . Value in Health, 4(2), 71-71.
- . Value in Health, 4(2), 64-64.
- . Value in Health, 4(6), 408.
- . Age Ageing, 30(4), 337-343.
- . Phlebology: The Journal of Venous Disease, 16(1), 29-33.
- . Lancet, 358(9287), 1077-1081.
- . J Health Serv Res Policy, 5(4), 214-218.
- . J Adv Nurs, 31(5), 1063-1071.
- . British Journal of Surgery, 87(4), 515-515.
- . Pharmacoeconomics, 17(2), 151-165.
- Decision analytic modelling in the economics evaluation of health care technologies: a consensus statement. PharmacoEconomics(4), 161-163.
- Decision Analytic modelling in the Economic Evaluation of Health Technologies: A consensus statement. PharmacoEconomics, 5(17), 443-444.
- . Health Technology Assessment, 4(11).
- . Rheumatology (Oxford), 38(9), 870-877.
- . J Health Serv Res Policy, 4(3), 174-184.
- . J Health Serv Res Policy, 4(3), 161-163.
- . Complement Ther Med, 7(2), 91-100.
- A checklist for judging preference-based measures of health related quality of life: learning from psychometrics.. Health Econ, 8(1), 41-51.
- . Health Technology Assessment, 3(9).
- . Qual Health Care, 7(4), 209-221.
- Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1179-1188.
- Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1149-1158.
- The factor structure of the SF-36 Health Survey in 10 countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1159-1165.
- The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1167-1170.
- Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1203-1214.
- Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1171-1178.
- . J Clin Epidemiol, 51(11), 1115-1128.
- . Pharmacoeconomics, 13(4), 411-420.
- . Journal of Clinical Epidemiology, 51(11), 933-944.
- . J Public Health Med, 19(4), 397-402.
- . Thorax, 52(10), 879-887.
- . Br J Psychiatry, 169(4), 516-521.
- . J Health Serv Res Policy, 1(4), 232-237.
- . Qual Life Res, 5(2), 195-204.
- . J Public Health Med, 18(1), 67-77.
- . Osteoporosis International, 6(S1), 271-271.
- The report of the Clinical Care Group. Diabetic Medicine, 13(SUPPL. 4).
- . BMJ, 311(7013), 1166-1166.
- . BMJ, 311(6999), 217-222.
- . Health Econ, 4(4), 255-264.
- . Pharmacoeconomics, 7(5), 403-415.
- . Social Science & Medicine, 41(10), 1337-1338.
- EFFECTS OF HELICOPTER SERVICE ON SURVIVAL AFTER TRAUMA - REPLY. BRIT MED J, 311(7013), 1166-1166.
- EVALUATING TRANSLATIONS OF HEALTH-STATUS QUESTIONNAIRES - METHODS FROM THE IQOLA PROJECT. INT J TECHNOL ASSESS, 11(3), 525-551.
- Quality of minor surgery by general practitioners in 1990 and 1991.. Br J Gen Pract, 44(385), 364-365.
- . Injury, 25(3), 145-153.
- . Pharmacoeconomics, 5(2), 109-122.
- . Gut, 35(9), 1294-1300.
- THE SF-36 HEALTH SURVEY - DEVELOPMENT AND USE IN MENTAL-HEALTH RESEARCH AND THE IQOLA PROJECT. INT J MENT HEALTH, 23(2), 49-73.
- . Injury, 25(10), 690.
- . Health Econ, 2(3), 213-215.
- . BMJ, 307(6901), 413-417.
- Laparoscopic versus mini-incision cholecystectomy.. Lancet, 341(8836), 47-48.
- . Health Economics, 1(3), 208-209.
- . BMJ, 305(6854), 645-646.
- . BMJ, 305(6854), 646-646.
- . BMJ, 305(6846), 160-164.
- . Gut, 33(11), 1553-1558.
- . The Lancet, 340(8823), 801-807.
- Cost effectiveness of minor surgery in general practice: a prospective comparison with hospital practice.. Br J Gen Pract, 42(354), 13-17.
- Information needs in a provider market: a case-study of ENT.. J Public Health Med, 13(2), 108-114.
- The funding debate revisited: who's for the mixed economy?. Health Serv Manage, 87(2), 84-86.
- AN ECONOMIC-REVIEW OF THE NHS WHITE PAPER. SCOT J POLIT ECON, 38(1), 96-105.
- . The Lancet, 334(8675), 1327-1329.
- . The Lancet, 334(8653), 51.
- . Br Med J (Clin Res Ed), 295(6603), 898-900.
- . Br Med J (Clin Res Ed), 295(6602), 836-838.
- . Financial Accountability and Management, 1(2), 173-189.
- Moving resources. Subregional RAWP--Hobson's choice?. Health and social service journal, 95(4963), 1064-1065.
- Equity and efficiency: clarifying the confusion for English acute hospitals.. Financial Accountability and Management, 2(1), 173-189.
- Producing a preference-based quality of life measure to quantify the impact of hypoglycaemia on people living with diabetes: a mixed-methods research protocol. Diabetic Medicine.
- . Scientific Reports, 12(1).
- Disease-specific assessment of Vision Impairment in Low Luminance (VILL) in age-related macular degeneration – a MACUSTAR study report. British Journal of Ophthalmology.
- Estimation of a Canadian preference-based scoring algorithm for the Veterans RAND 12-item Health Survey (VR-12): a population survey using a discrete choice experiment. CMAJ open.
- . PharmacoEconomics.
- . Quality of Life Research.
- Valuing child and adolescent health: A qualitative study on different perspectives and priorities taken by the adult general public. Health and Quality of Life Outcomes.
- Measuring What Matters – Little Evidence Supporting the Content Validity of EQ-5D in People with Duchenne Muscular Dystrophy and Their Caregivers. Medical Decision Making.
- . Quality of Life Research.
- . PharmacoEconomics.
- Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment.
- Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations. Value in Health.
- Deriving a Preference-based Measure for People with Duchenne Muscular Dystrophy from the DMD-QoL. Value in Health.
- . Neurology, 10.1212/WNL.0000000000011896-10.1212/WNL.000000000.
- What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality adjusted life years? Application to the development of the EQ-HWB?. European Journal of Health Economics.
- Clinical and cost-effectiveness of person-centred experiential therapy vs. cognitive behavioural therapy for moderate and severe depression delivered in the English Improving Access to Psychological Therapies national programme: A pragmatic randomised non- inferiority trial [PRaCTICED]. The Lancet Psychiatry.
- . PharmacoEconomics.
Chapters
- , International Encyclopedia of Public Health (pp. 586-593). Elsevier
- , Encyclopedia of Health Economics (pp. 130-138). Elsevier
- , Encyclopedia of Health Economics (pp. 358-365). Elsevier
- In Jones A (Ed.), The Elgar Companion to Health Economics, Second Edition (pp. 395-405).
- (pp. 787-813). Oxford University Press
- Identifying and reviewing health state utility values for populating decision models In Shemilt I, Mugford M, Vale L, Donaldson C & Marsh K (Ed.), Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice (pp. 93-105). Wiley-Blackwell
- SF-6D In Kattan MW & Cowen ME (Ed.), Encyclopaedia of Medical Decision Making California: Sage Publications.
- The measurement and Valuation of Health for Economic Evaluation. In Heggenhougen HK & Quah S (Ed.), International Encyclopaedia of Public Health. (pp. 252-261). San Diego: Academic Press.
- Methods for developing preference-based measures of Health. In Jones A (Ed.), The Elgar Companion to Health Economics (pp. 371-381). Cheltenham UK: Edward Elgar Publishing Ltd.
- (pp. 147-148). Association for Computing Machinery (ACM)
- , Studying the Organisation and Delivery of Health Services (pp. 176-187).
- Modelling health state valuation data In Murray C, Saloman J, Mathers C & Lopez A (Ed.), Summary Measures of Population Health 2002: Concepts, Ethics, Measurement and Applications (pp. 529-548). World Health Organisation
- Economic evaluation of complementary therapies, Clinical Research in complementary therapies London: Churchill Livingstone.
- The use of health related quality of life questionnaires in economic evaluation. In Stevens A, Abrams K, Brazier J, Fitzpatrick R & Lilford R (Ed.), Methods in Hdealth Technology Assessment London: Sage Books.
- Tolerant Building: The impact of energy efficiency measures on living conditions and health status In Rudge J & Nical F (Ed.), Cutting the cost of cold: Affordable warmth for healthier homes (pp. 87-106). London: Taylor & Francis.
- The use of health related quality of life questionnaires in economic evaluation. In Black N, Fitzpatrick R & Reeves B (Ed.), Methods for Health Services Research: a state of the art guide. London: BMJ Books.
- The SF-36 Health Survey and its use in Pharmacoeconomics economic evaluation., Quality of Life Assessment Auckland: Adis International.
- Economic Evaluation in Brief In Earlam RJ (Ed.), The Royal Hospital Trauma Hospital - A Trauma Care System London.
- Health Care Needs Assessment: Accident and Emergency Departments. In Stevens A & Raftery J (Ed.), Health Care Needs Assessment Frome: Radlcliffe Medical Press.
- An economic perspective on health outcome measurement. In Hutchinson & et al (Ed.), Outcome Measurement in Primary Care Amsterdam: Harwood academic publishers.
- The economics of diabetic care In Bradley C, Christine M & West R (Ed.), The technology of diabetic care London: Harwood.
- Evaluating the reform of the NHS In Culyer AJ, Maynard A & Posnett J (Ed.), Competition in Health Care: reforming the NHS London: MacMillan Press.
- The White Paper and the NHS: How much competition will there actually be?, Health Care UK Newbury: Policy Journals.
- District health authorities as trading organisations., Health Care UK Newbury: Policy Journals.
Conference proceedings papers
- . Value in Health, Vol. 25(7) (pp S574-S574)
- . Value in Health, Vol. 25(7) (pp S546-S546)
- . Abstracts (pp a32.1-a3a32)
- VALUATION OF SF-6D HEALTH STATES: IS IT FEASIBLE AND ACCEPTABLE IN A LEBANESE POPULATION. VALUE IN HEALTH, Vol. 25(7) (pp S574-S574)
- THE OPUF TOOL: A NEW TYPE OF ONLINE SURVEY FOR CREATING VALUE SETS FOR THE EQ-5D-5L ON THE SOCIETAL-, GROUP-, AND INDIVIDUAL PERSON LEVEL. VALUE IN HEALTH, Vol. 25(7) (pp S546-S546)
- PARTICIPANT REINTERPRETATION OF HEALTH STATES: A THINK-ALOUD STUDY OF DECISION-MAKING STRATEGIES IN DISCRETE CHOICE EXPERIMENTS WITH THE SF-6DV2. VALUE IN HEALTH, Vol. 25(7) (pp S551-S551)
- BRIDGING AND VALIDATION OF A THYROID EYE DISEASE (TED) SPECIFIC QUALITY OF LIFE (QOL) QUESTIONNAIRE TO UTILITY VALUES ASSESSED BY A TIME TRADE-OFF (TTO) ANALYSIS. VALUE IN HEALTH, Vol. 25(7) (pp S531-S531)
- A NEW ONLINE TOOL FOR VALUING HEALTH STATES: ELICITING PERSONAL UTILITY FUNCTIONS FOR THE EQ-5D-5L. VALUE IN HEALTH, Vol. 25(1) (pp S13-S13)
- Psychometric properties of the Vision Impairment in Low Luminance (VILL) questionnaire in age-related macular degeneration in the MACUSTAR study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 62(8)
- Preference Study in Childhood Autism Spectrum Disorder (ASD) using the Childhood Autism Rating Scale (CARS2): A Feasibility Assessment. QUALITY OF LIFE RESEARCH, Vol. 30(SUPPL 1) (pp S113-S114)
- DEVELOPMENT OF THE SF-6DV2 HEALTH UTILITY SURVEY: CONTENT VALIDITY AND PATIENT PREFERENCE. VALUE IN HEALTH, Vol. 24 (pp S193-S193)
- . Value in Health, Vol. 23 (pp S319-S319)
- . Value in Health, Vol. 23 (pp S325-S325)
- TEST-RETEST RELIABILITY OF COMPOSITE TTO AND DCE WITH DURATION IN THE VALUATION OF SF-6DV2 HEALTH STATES. VALUE IN HEALTH, Vol. 23 (pp S319-S319)
- DEVELOPMENT OF A PREFERENCE BASED SINGLE INDEX FOR THE VR-12 IN CANADA. MEDICAL DECISION MAKING, Vol. 40(1) (pp E53-E54)
- HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA PATIENTS: DETERMINATION OF UTILITY VALUES FROM A UK-BASED CLINICIAN QUESTIONNAIRE. VALUE IN HEALTH, Vol. 23 (pp S715-S715)
- FAIR INTERPERSONAL UTILITY COMPARISON IN THE CONTEXT OF HEALTH VALUATION: DESCRIPTION AND FIRST EMPIRICAL EVALUATION OF A NEW MULTI-STEP PREFERENCE AGGREGATION PROCEDURE. MEDICAL DECISION MAKING, Vol. 40(5) (pp E407-E408)
- Extending the QALY (E-QALY): developing a new generic preference-based measure for use with patients, carers and those needing care-an overview. QUALITY OF LIFE RESEARCH, Vol. 29(SUPPL 1) (pp S3-S3)
- ADAPTING PREFERENCE-BASED UTILITY MEASURES TO CAPTURE THE IMPACT OF CANCER TREATMENT-RELATED SYMPTOMS. VALUE IN HEALTH, Vol. 23 (pp S430-S430)
- . Value in Health, Vol. 22(Suppl 3) (pp S664-S664). Copenhagen, Denmark, 2 November 2019 - 6 November 2019.
- . Value in Health, Vol. 22 (pp S685-S686)
- . Value in Health, Vol. 22(Suppl. 3) (pp S891-S891). Copenhagen, Denmark, 2 November 2019 - 6 November 2019.
- MAPPING FROM VISUAL ACUITY TO UTILITY IN PATIENTS WITH MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION USING DATA FROM THE LEAVO TRIAL. VALUE IN HEALTH, Vol. 22 (pp S891-S891)
- DEVELOPMENT OF THE CYSTIC FIBROSIS QUESTIONNAIRE-REVISED PREFERENCE BASED SCORING ALGORITHM. PEDIATRIC PULMONOLOGY, Vol. 54 (pp S443-S443)
- Extending the QALY project in the United States: face and content validity of items for a new preference-based measure. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S165-S165)
- Using item response theory to construct a health classification system and select health states for valuation for the Preference-Based Index from the Recovering Quality of Life (ReQoL) outcome measure. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S68-S68)
- How to capture fluctuating health impairments in people with multiple sclerosis: development of an intensive longitudinal assessment of the EQ-5D-5L. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S164-S164)
- UK utility weights for the cancer-specific EORTC QLU-C10D: Why, how and when to use?. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S11-S12)
- Extending the QALY: developing and testing the proposed items for a new generic measure - results from qualitative review and face validity with patients, social care users and carers. QUALITY OF LIFE RESEARCH, Vol. 27 (pp S189-S189)
- Interpreting changes in scores: the case of the Recovering Quality of Life (ReQoL). QUALITY OF LIFE RESEARCH, Vol. 27 (pp S161-S161)
- . Value in Health, Vol. 21 (pp S110-S110)
- . Quality of Life Research, Vol. 27(7) (pp 1893-1902)
- . The Patient - Patient-Centered Outcomes Research, Vol. 11(1) (pp 29-37)
- Development of United Kingdom value set for EORTC QLU-C10D: multi-attribute utility classification for the EORTC-QLQ-C30. QUALITY OF LIFE RESEARCH, Vol. 26(1) (pp 50-50)
- . Health and Quality of Life Outcomes, Vol. 15(S1)
- Changing HbA(1c) units: a hindarance, not a help to patients. DIABETOLOGIA, Vol. 60 (pp S342-S342)
- . Value in Health, Vol. 19(7) (pp A571-A571)
- . Value in Health, Vol. 19(7) (pp A385-A385)
- . Value in Health, Vol. 19(7) (pp A513-A513)
- . Value in Health, Vol. 19(7) (pp A379-A379)
- . Value in Health, Vol. 19(7) (pp A807-A807)
- . Value in Health, Vol. 19(7) (pp A389-A389)
- . Health and Quality of Life Outcomes, Vol. 14(Suppl 1), 9 June 2016 - 9 June 2016.
- Developing a PROM to evaluate self-management in diabetes (HASMID): giving patients a voice. HEALTH AND QUALITY OF LIFE OUTCOMES, Vol. 14
- Well-being: what is it, how does it compare to health and what are the implications of using it to inform health policy. HEALTH AND QUALITY OF LIFE OUTCOMES, Vol. 14
- Valuing the impact of self-management on quality of life in diabetes using discrete choice experiments. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 134-134)
- Factor analyses identified one dominant global factor in a new scale for recovering quality of life (ReQoL) for mental health patients. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 95-95)
- First validation of the short recovering quality of life (ReQoL) measure. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 96-96)
- Constructing the short recovering quality of life (ReQoL) measure for use in a mental health population: combining psychometric and qualitative evidence. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 70-70)
- Developing the recovery of quality of life measure (ReQoL): the views of mental health service users on potential items. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 46-47)
- Prevalence of Metamorphopsia in Patients with Vitreomacular Traction and its Impact on Quality of Life: The MeMo Study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 57(12)
- . Value in Health, Vol. 19(3) (pp A190-A190)
- Improvements in health-related quality of life measured by SF-36 and EQ-5D in patients with moderate to severe plaque psoriasis treated with brodalumab. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, Vol. 74(5) (pp AB256-AB256)
- . Value in Health, Vol. 19(3) (pp A126-A126)
- . Value in Health, Vol. 19(3) (pp A94-A94)
- . Value in Health, Vol. 18(7) (pp A744-A744)
- Does EQ-5D-5L account for the impact of limitations in activities of daily livings (ADLS) on social care outcomes, capabilities and well-being?. QUALITY OF LIFE RESEARCH, Vol. 24 (pp 179-179)
- The Willingness to Pay for Improvements in Insulin Injectable Therapies for People with Type 2 Diabetes in North America. DIABETES, Vol. 64 (pp A349-A349)
- The Willingness to Pay for Improvements in Insulin Injectable Therapies for People with Type 2 Diabetes in the UK, France, and the Netherlands. DIABETES, Vol. 64 (pp A349-A349)
- . Value in Health, Vol. 18(3) (pp A210-A211)
- DO CANCER PATIENTS DISTINGUISH BETWEEN THE IMPORTANCE AND SEVERITY OF THEIR QUALITY OF LIFE CONCERNS?. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 10 (pp 31-31)
- THE DEVELOPMENT OF CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENTS FROM THE EORTC QLQ-C30 AND FACT-G. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 10 (pp 31-31)
- Health-related quality of life and well-being. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 62-62)
- Do cancer patients distinguish between the importance and severity of their quality of life concerns?. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 122-122)
- Comparison of an online survey and face-to-face interviews for eliciting societal preferences. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 49-49)
- PROMs in Secondary Mental Health Services in the UK: a Feasibility Study and Lessons Learnt. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, Vol. 17 (pp S10-S10)
- . Value in Health, Vol. 17(3) (pp A194-A194)
- . VALUE IN HEALTH, Vol. 16(7) (pp A386-A387)
- . Value Health, Vol. 16(3) (pp A26). United States
- . VALUE IN HEALTH, Vol. 15(7) (pp A605-A606)
- THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 8 (pp 335-335)
- Valuing a vision 'bolt-on' item for the EQ-5D. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 53-54)
- Appropriate mapping functions in HRQL: a series of models mapping from FACT-G to EQ-5D. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 11-11)
- How do respondents perceive health state valuation tasks? A 'think aloud' study investigating time trade off and discrete choice experiments. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 53-53)
- THE DEVELOPMENT AND VALUATION OF THE SHEFFIELD PREFERENCE BASED LEG ULCER QUESTIONNAIRE (SPVU-5D). VALUE IN HEALTH, Vol. 15(4) (pp A126-A126)
- . VALUE IN HEALTH, Vol. 15(4) (pp A225-A225)
- The impact of adding a generic dimension to a condition-specific preference-based measure. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 10-10)
- Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to Preference-based Values Measured by SF-6D in Patients with Colorectal Neoplasm. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 26-26)
- Adaptation of a method for developing a preference-based measure from a descriptive health-related quality of life measure (HRQOL): a confirmatory versus exploratory approach for the cancer-specific QLQ-C30. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 31-31)
- The impact of condition labelling on health state utility values. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 11-11)
- . VALUE IN HEALTH, Vol. 14(7) (pp A428-A428)
- . VALUE IN HEALTH, Vol. 14(7) (pp A462-A462)
- . VALUE IN HEALTH, Vol. 14(7) (pp A427-A427)
- . VALUE IN HEALTH, Vol. 14(7) (pp A239-A239)
- . VALUE IN HEALTH, Vol. 14(7) (pp A242-A242)
- . VALUE IN HEALTH, Vol. 14(7) (pp A457-A457)
- ESTIMATING HEALTH STATE UTILITY VALUES FOR COMORBID HEALTH CONDITIONS. VALUE HEALTH, Vol. 13(7) (pp A334-A335)
- ESTIMATING THE SF-6D VALUE SET FOR A POPULATION BASED SAMPLE OF BRAZILIANS. VALUE HEALTH, Vol. 13(7) (pp A240-A240)
- What do people with dementia and their proxies say about HRQL? A quantitative test of qualitative findings. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 14-14)
- Using the Liverpool Quality of Life battery to develop a health state classification system for Epilepsy. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 57-57)
- Developing a health state classification system for dementia using Rasch analysis. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 35-36)
- A COMPARISON OF THE DISCRIMINTATIVE AND EVALUATIVE PROPERTIES OF THE SF-36 AND THE SF-6D INDEX. VALUE HEALTH, Vol. 13(3) (pp A17-A17)
- MEASUREMENT OF HEALTH UTILITY VALUES IN THE UK FOR HEALTH STATES RELATED TO IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA (ITP). VALUE HEALTH, Vol. 12(7) (pp A383-A383)
- COST-EFFECTIVENESS OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIIA INHIBITOR IN THE TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION-A HORIZONS TRIAL ANALYSIS USING UK VALUATIONS. VALUE HEALTH, Vol. 12(7) (pp A334-A335)
- THE IMPACT OF DISEASE ADAPTATION ON GENERAL POPULATION VALUES. VALUE HEALTH, Vol. 12(3) (pp A35-A35)
- . Value in Health, Vol. 12(1) (pp 159-166)
- IN OR OUT? EMPIRICAL EVIDENCE ON INCOME LOSSES IN HEALTH STATE VALUATIONS AND IMPLICATIONS FOR ECONOMIC EVALUATIONS. VALUE HEALTH, Vol. 11(6) (pp A563-A564)
- Predicting a mean EQ-5D preference-based score from the 8 mean SF-36 dimension scores when individual data is not available. VALUE HEALTH, Vol. 11(3) (pp A178-A179)
- Predicting SF-6D preference-based utilities using mean SF-36 health dimension scores when patient level data are not available. VALUE HEALTH, Vol. 11(3) (pp A178-A178)
- . Nucleosides Nucleotides Nucleic Acids, Vol. 26(6-7) (pp 555-558). United States
- . Nucleosides Nucleotides Nucleic Acids, Vol. 26(6-7) (pp 709-712). United States
- Outcome of tailored psychotherapy for nonepileptic seizures and other functional neurological symptoms. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 78(9) (pp 1016-1016)
- Health state utility values in rheumatic diseases - A review. ANNALS OF THE RHEUMATIC DISEASES, Vol. 66 (pp 256-256)
- A probabilistic cost-effectiveness analysis of psychological therapies including dialectical behaviour therapy for borderline personality disorder.. J MENT HEALTH POLICY, Vol. 10 (pp S18-S19)
- Psychological therapies for borderline personality disorder: A systematic review. J MENT HEALTH POLICY, Vol. 10 (pp S5-S6)
- Mapping generic quality of life measurements to disease specific variables in patients with Ankylosing Spondylitis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 273-273)
- . Value in Health, Vol. 9(3) (pp A98-A98)
- Estimating a preference-based index from a condition specific measure - The King's Health Questionnaire. VALUE HEALTH, Vol. 9(3) (pp A97-A98)
- ESTIMATING HEALTH STATE VALUATION MODELS FROM ORDINAL HEALTH STATE PREFERENCE DATA (RANK AND DISCRETE CHOICE EXPERIMENTS) AND COMPARING TO TTO VALUATIONS. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2110-2110)
- ESTIMATING A PREFERENCE-BASED SINGLE INDEX FROM THE ASTHMA QUALITY OF LIFE QUESTIONNAIRE. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2012-2012)
- USING RASCH ANALYSIS TO AID THE CONSTRUCTION OF PREFERENCE BASED MEASURES FROM EXISTING QUALITY OF LIFE INSTRUMENTS. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2081-2081)
- COMPARISON OF THE HUI-3 AND SF-6D IN PATIENTS WITH LATENT AND ACTIVE TUBERCULOSIS. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2020-2020)
- Quality-adjusted survival and cost-effectiveness of transmyocardial revascularization using the CO2 laser. CIRCULATION, Vol. 111(20) (pp E319-E319)
- A prospective clinical trial of the management and outcome of uncomplicated varicose veins. BRITISH JOURNAL OF SURGERY, Vol. 92(4) (pp 506-506)
- Randomized trial of treatment for uncomplicated varicose veins: surgery is clinically and cost effective. BRITISH JOURNAL OF SURGERY, Vol. 92(4) (pp 506-507)
- An exploration of the discrepancies between health state valuations of patients and the general population. VALUE HEALTH, Vol. 7(6) (pp 775-775)
- A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. MEDICAL CARE, Vol. 42(11) (pp 1125-1131)
- The cost-effectiveness of bisphosphonates, raloxifene and teriparatide in women with a prior fracture, low BMD and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S39-S39)
- The cost-effectiveness of calcium and vitamin D in women with low dietary calcium intake. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S39-S40)
- COMPARISON OF PATIENT AND GENERAL POPULATION VALUES: THE CASE OF VARICOSE VEINS. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1557-1557)
- A COMPARISON OF PREFERENCE-BASED MEASURES IN PATIENTS WITH AGE RELATED MACULAR DEGENERATION. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1509-1509)
- PATIENT INVOLVEMENT IN VALUING HEALTH STATES FOR USE IN ECONOMIC EVALUATION. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1571-1571)
- PILOT TEST OF SF-6D VALUATION SURVEY ON CHINESE ADULTS IN HONG KONG. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1509-1509)
- The cost-effectiveness of bisphosphonates, raloxifene and hormone replacement therapy in women with established osteoporosis and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S111-S111)
- The cost-effectiveness of calcium and vitamin D supplementation in women with low dietary intake of these nutrients and at risk of osteoporosis. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S87-S88)
- Developing a preference-based measure for postmenopausal health. VALUE HEALTH, Vol. 6(6) (pp 606-606)
- The efficacy of clodronate (Bonefos (R)) to reduce the incidence of osteoporotic fractures in elderly women is independent of the underlying BMD.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S92-S92)
- SF-36 and EQ-5D in adult ICU patients. INTENSIVE CARE MEDICINE, Vol. 29 (pp S176-S176)
- Justifying the development of a lay panel to produce utilities for use in health technology assessments (HTAS): Review of current issues,and views of technology appraisal committee members. VALUE HEALTH, Vol. 6(3) (pp 305-305)
- A within subject comparison of four indirect utility measures in rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S74-S74)
- Comparison of health state utilities using community and patient preference weights derived from a survey of patients with rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S74-S74)
- Cost-effectiveness of current treatments for established female osteoporosis. OSTEOPOROSIS INT, Vol. 11 (pp S11-S11)
- Effects of clodronate on hip BMD in community-dwelling women: Randomised trial: 1 year results.. J BONE MINER RES, Vol. 12 (pp S490-S490)
- ORAL CLODRONATE PREVENTS BONE LOSS AT THE HIP IN ELDERLY WOMEN - A PILOT-STUDY. J BONE MINER RES, Vol. 10 (pp S356-S356)
- TRANSLATING HEALTH - THE INTERNATIONAL QUALITY-OF-LIFE ASSESSMENT (IQOLA) PROJECT. QUAL LIFE RES, Vol. 3(1) (pp 66-66)
- COMPARISON OF HEALTH-STATUS MEASUREMENT MODELS AND THE VALIDITY OF SF-36 IN GREAT-BRITAIN, SWEDEN AND THE USA. QUAL LIFE RES, Vol. 3(1) (pp 68-68)
- Health state valuation for ARMD visual impairment states using simulation lenses. 6th iHEA World Congress on Health Economics. Copenhagen, Denmark, July 2007.
- A Condition-Specific Preference-Based Instrument: The Asthma Quality of Life Utility Index (AQL-5D)
Reports
- Estimating a Preference-Based Index for mental health from the Recovering Quality of Life (ReQoL) measure: Valuation of ReQoL-UI
- Measuring and valuing health-related quality of life when sufficient EQ-5D data is not available
- A review of the psychometric performance of paediatric preference-based measures used to generate utility values for children
- An empirical comparison of well-being measures used in the UK
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia.
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular.
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer.
- Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy
- . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer.
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audit Work Package 2. How should PROMS data be collected?
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme.
- A conceptual comparison of well-being measures used in the UK.
- Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Part 1, Executive summary, introduction, clinical reviews and conceptual modelling.
- Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Part 2. Independent economic evaluation: methods and results, discussion and conclusion
- Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Appendices.
- Update: Eliciting societal preferences for weighting QALY's according to burden of illness, size of gain and end of life
- Examining productivity losses associated with health related quality of life using patient and general population data.
- Eliciting societal preferences for burden of illness, therapeutic improvement and end of life for value based pricing: a report of the main survey
- Case-mix methodology for the NHS outcomes framework GP Patient Survey Questionnaire Data
- Evaluating public health interventions for obesity from the perspective of local health authorities.
- An evaluation of a new service model: Improving Access to Psychological Therapies demonstration sites 2006-2009. Final report. NIHR Service Delivery and Organisation programme
- An evaluation of a new service model: Improving Access to Psychological Therapies demonstration sites 2006-2009, Final Report.
- NICE DSU Technical Support Document 11: Alternatives to EQ-5D for generating health state utility values
Scholarly editions
- Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report.
- Using rank and discrete choice data to estimate health state utility values on the QALY scale.
- A qualitative study exploring the general population’s perception of rheumatoid arthritis after being informed about disease adaptation.
- The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results.
- Combining Rasch and cluster analysis: a novel method for developing rheumatoid arthritis states for use in valuation studies.
- .
- Does the National Institute for Health and Clinical Excellence take account of factors such as uncertainty and equity as well as incremental cost-effectiveness in commissioning health care services? A binary choice experiment.
Posters
- P60 A New Online Tool for Valuing Health States: Eliciting Personal Utility Functions for the EQ-5D-5L.
- E-QALY: valuing the items for a new generic preference-based measure using time trade-off and discrete choice experiments.
- DEVELOPMENT OF THE SCHARR HUD (HEALTH UTILITIES DATABASE).
- Estimating a Preference-Based Index from the Recovering Quality of Life measure for economic evaluation in the area of mental health: Valuation of ReQoL-UI.
- Constructing a classification system for a new QALY measure in mental health: recovering quality of life (ReQoL).
- ReQoL: Recovering Quality of LIfe.
- Development of the Recovering Quality of Life Measure (2014).
- First validation of the Recovering Quality of Life measures: a new PROM for use in mental health.
- Does the generic cancer outcome measure EORTC QLQ-C30 work in Myelofibrosis? (ISPOR 20th Annual International Meeting 16-20 May 2015).
- Development of a preference-based, condition specific patient reported outcome measure for use with venous ulceration (2012).
- Examining the incremental impact of long-standing health conditions on subjective well-being – is there anything missing from the EQ-5D? (ISPOR 18th Annual International Meeting 18-22 May 2013).
- Are general population data suitable for approximating baseline utility values in economic models?.
- Selection of bolt-ons after factor analysis identification: are linear regression models a useful technique?.
- ReQol - Recovering Quality of Life (Quality in Mental Health Conference 23 March 2015).
- The impact of conditions labels on health state values.
- Estimating SF-6D health state utility values for comorbid health conditions.
- Policy Research Unit in Economic Evaluation of Health and Care Interventions.
Datasets
Presentations
Other
- . Value in Health.
- . Quality of Life Research, 26(8), 2247-2248.
- . Quality of Life Research, 25(9), 2401-2401.
- . Quality of Life Research, 25(10), 2683-2683.
- . Value in Health, 16(1), 217-218.
- . BRIT J PSYCHIAT, 197(5), 348-349.
- . BMJ (Online), 341(7776), 746.
- . HEALTH ECON, 16(7), 759-761.
- . Health Econ, 16(6), 645-647.
- . QJM, 99(5), 348-349.
- . Health Econ, 15(5), 527-533.
- Comparison of outcome measures in patients with COPD - Reply. THORAX, 53(9), 813-813.
- HEALTH-STATUS MEASUREMENT - A PERSPECTIVE ON CHANGE - BROOKS,RG. HEALTH ECON, 4(2), 149-150.
- SKIN BIOPSIES BY GPS. BRIT J GEN PRACT, 43(376), 478-478.
- . LANCET, 341(8836), 47-47.
- Management of trauma [20]. British Medical Journal, 307(6905), 683-684.
- VALIDATING THE SF-36 - REPLY. BRIT MED J, 305(6854), 646-646.
- PERFORMANCE OF SKIN BIOPSIES BY GENERAL-PRACTITIONERS. BRIT MED J, 303(6815), 1472-1472.
- CASELOAD OR WORKLOAD. BRIT MED J, 301(6751), 556-556.
- HORMONE REPLACEMENT THERAPY FOR OSTEOPOROSIS. LANCET, 335(8695), 978-978.
- BENEFITS OF INVITRO FERTILIZATION. LANCET, 2(8675), 1327-1328.
- .
Preprints
- Research group
-
- Professional activities and memberships
-
- NIHR Senior Investigator award 2009-2017
- Membership of the .
- Fellow of the Academy of Medical Sciences